Abstract Details

Title Fourteen Year Interim Results from an International Observational Study of Pregnancy Outcomes Following Exposure to Lamotrigine

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marianne C. Cunnington, PhD (GlaxoSmithKline)	No disclosure on file
Agustina Tamargo	No disclosure on file
John A. Messenheimer, Jr., MD	Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��